Supply Chain Disruption – Again

The UK's e-bike trade remedy review demonstrates how economic modelling can balance domestic industry protection against broader public interest. Through partial-equilibrium analysis, the UK Trade Remedies Authority quantified the costs and benefits of different remedial options, ultimately recommending modified measures that protected UK producers in specific segments while minimizing consumer impact.

The Comprehensive and Progressive Agreement for Trans-Pacific Partnership entered into force between Canada and the United Kingdom on September 1, 2026, fundamentally reshaping bilateral trade relations and investment frameworks. This development arrives as Canada actively diversifies away from U.S. trade dependence while the UK advances its post-Brexit global strategy, creating expanded market access for businesses on both sides of the Atlantic.

HM Revenue and Customs has issued its largest sanctions-related compound penalty to date, fining Illumina Cambridge Limited over £7.4 million for breaches of UK Russian sanctions. The company was penalized for its involvement in the supply of sanctioned goods between overseas companies within its corporate group for export to Russia and other destinations between July 2022 and January 2023.

Vaping duty stamps are highly secure labels indicating that the vaping product is legal. They must be rectangular, meet specific dimension requirements and be made from bespoke secure paper

The UK sanctions framework is undergoing significant changes that will impact how organisations maintain compliance. With OFSI introducing revised penalty structures, new discount mechanisms, and tighter settlement timelines, understanding these developments is critical for businesses operating under financial sanctions regimes.

The UK-India Free Trade Agreement creates significant opportunities for Indian businesses to access the UK market through reduced tariffs and streamlined customs procedures. While the agreement lowers trading barriers, businesses must navigate complex regulatory compliance requirements including product standards, labelling obligations, and sector-specific approvals to successfully establish their presence in the United Kingdom.

Welcome to BCL’s latest sanctions round-up, highlighting the key developments in UK and international sanctions

Welcome to BCL’s latest sanctions and export controls round-up, highlighting the key developments in UK and international sanctions

The UK Department of Transport has disclosed details of a recent maritime incident involving a Russian-flagged cargo vessel that sought entry into British territorial waters for emergency repairs. Following a sanctions investigation by the Centre for Transport Sanctions, authorities exercised discretionary powers to issue a movement direction, compelling the vessel to depart UK waters.

The EU's e-Evidence Package introduces a direct cross-border framework allowing authorities to compel electronic evidence from service providers through binding Production and Preservation Orders. U.S. companies offering cloud, communications, or data-driven services to EU users face immediate operational obligations including appointing EU representatives, meeting shortened response windows, and navigating potential conflicts with U.S. law.

September 2026 marks the first anniversary of the corporate criminal offence of failure to prevent fraud coming into force under section 199 of the Economic Crime and Corporate Transparency Act 2023 (ECCTA). The Home Office guidance recommends that organisations review their fraud prevention measures at least every 12 months.

Between 2021 and 2025, Medicaid spending on ABA therapy grew six times faster than the number of children who received services, making it one of the fastest-growing areas of Medicaid expenditure, according to CMS. On August 4, 2026, CMS released a toolkit to help state Medicaid and CHIP agencies strengthen their programs and limit fraud, waste, and abuse tied to increased demand for ABA therapy.

Following the holiday weekend, the Federal Trade Commission (FTC) announced a proposed settlement with Humboldt Merchant Services requiring the payment processor to pay $12 million...

Manufacturers of connected products must now comply with the EU Cyber Resilience Act's vulnerability and incident reporting obligations through ENISA's newly launched Single Reporting Platform. This comprehensive guide addresses the critical question every manufacturer faces: can your organization report a cybersecurity incident within 24 hours if one occurs tonight?

Over the past several years, the biopharmaceutical industry has embraced artificial intelligence and machine learning (AI/ML) in near lockstep with the pace of AI/ML innovations. Today, industry leaders are using AI/ML to, among other things: discover and assess biological pathways, target chemical structures and sequences; design proteins; model pre-clinical and clinical trials; recruit and screen potential patient populations; evaluate clinical trial results and biomarker data; prepare regulatory filings; and manage supply chains. Deployment of new AI/ML models promises extraordinary advances in pharmaceutical development. However, as with any technological and scientific advances, the use of AI/ML also poses substantial legal risks that life sciences companies need to consider and proactively manage.

On September 8, 2026, the U.S. Department of Labor’s (DOL) Employee Benefits Security Administration (EBSA) issued “Field Assistance Bulletin No. 2026-03” to clarify compliance with the Mental Health Parity and Addiction Equity Act (MHPAEA) and nonquantitative treatment limitations (NQTL). Under the 2013 final rule implementing MHPAEA, health plans and issuers must use comparable processes, strategies, evidentiary standards, or other factors when applying NQTLs and they cannot apply such methods more stringently to benefits for mental health and substance use disorder (MH/SUD) compared to benefits for general medical and surgical care. While the bulletin doesn’t break much new ground on compliance, it does reaffirm existing enforcement priorities and expectations.

On September 2, 2026, the National Archives and Records Administration (NARA), through its Information Security Oversight Office (ISOO), released two new Notices on the topic of Controlled Unclassified Information (CUI).

The Federal Trade Commission takes decisive action on multiple fronts, from scrutinizing healthcare mergers in Ohio to extending comment periods on personalized pricing policies. Meanwhile, a major payment processor faces millions in penalties for allegedly facilitating merchant fraud and deceptive telemarketing schemes.

State attorneys general across the nation are taking decisive action on healthcare access, environmental regulation, consumer protection, and voting rights. From challenging federal restrictions on gender-affirming care to blocking changes in mail voting procedures, these legal battles reveal the growing tension between state authority and federal policy. Will these multistate coalitions succeed in preserving state sovereignty over critical public services?

Five foundational ISDS decisions reveal how investment tribunals balance Indigenous consultation rights under ILO Convention 169 with treaty protections for foreign mining investors. This analysis examines the evolving legal framework governing State obligations, social license requirements, and the circumstances under which community opposition triggers treaty liability.